Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 16/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10034349 | 0.98 | PDK2 (0.37) | PDK2CYP11B1GPR84ALDH1A1HPGD | |
| SCHEMBL10034352 | 0.98 | PDK2 (0.37) | PDK2CYP11B1GPR84ALDH1A1HPGD | |
| SCHEMBL20102238 | 0.98 | PDK2 (0.34) | PDK2CYP11B1GPR84ALDH1A1HPGD | |
| SCHEMBL10034415 | 0.96 | PDK2 (0.34) | PDK2CYP11B1GPR84ALDH1A1HPGD | |
| SCHEMBL25793474 | 0.96 | CYP11B1 (0.35) | PDK2CYP11B1GPR84ALDH1A1HPGD | |
| SCHEMBL10034381 | 0.96 | PDK2 (0.32) | PDK2CYP11B1GPR84 | |
| SCHEMBL20102231 | 0.95 | PDK2 (0.37) | PDK2CYP11B1GPR84ALDH1A1HPGD | |
| SCHEMBL10034410 | 0.95 | PDK2 (0.37) | PDK2CYP11B1GPR84ALDH1A1HPGD | |
| SCHEMBL17243529 | 0.95 | PDK2 (0.34) | PDK2CYP11B1GPR84ALDH1A1HPGD | |
| SCHEMBL10034404 | 0.95 | PDK2 (0.37) | PDK2CYP11B1GPR84ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8980442-B2 | Aromatic amine derivative and organic electroluminescent element using same | MITSUI CHEMICALS, INC. (JP) | 2015-03-17 | — | — | US | disclosed |
| US-8980442-B2 | Aromatic amine derivative and organic electroluminescent element using same | MITSUI CHEMICALS, INC. (JP) | 2015-03-17 | — | — | US | disclosed |
| US-20120012832-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | MITSUI CHEMICALS, INC. (JP) | 2012-01-19 | — | — | US | disclosed |
| US-20120012832-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | MITSUI CHEMICALS, INC. (JP) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120012832-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | MAOA, MAOB, TYR | PDK2 1940/4885CYP11B1 1963/4885GPR84 3453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.